Chronic lymphocytic leukaemia: open trials in Mexico

• NCT05947851

  A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Centro de Infusion Superare ( Site 3314), Mexico City · Health Pharma Professional Research S.A. de C.V: ( Site 3301), Mexico City · Centro de Investigacion Clinica Chapultepec ( Site 3309), Morelia

  Registry updated 2026-10-15

• NCT06136559

  A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Grupo Médico ASSET SC ( Site 2611), Benito Juárez · Health Pharma Professional Research S.A. de C.V: ( Site 2608), Mexico City · Centro de Infusion Superare ( Site 2602), Mexico City

  Registry updated 2026-10-13

• NCT06973187

  A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

  Trial Treatment · Phase 3 · BeOne Medicines

  Centro de Investigacion Clinica Gramel, México · Christus Latam Hub Center of Excellence and Innovation Sc, Monterrey · Centro de Investigacion Clinica de Oaxaca, Oaxaca City · Centro Hemato Oncologico Privado de Toluca, Toluca

  Registry updated 2026-09-28

All Chronic lymphocytic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error